Home > Healthcare > Drug Device Combination > Therapeutic Systems > Oncolytic Virus Immunotherapy Market

Oncolytic Virus Immunotherapy Market Trends

  • Report ID: GMI8770
  • Published Date: Mar 2024
  • Report Format: PDF

Oncolytic Virus Immunotherapy Market Trends

  • Oncolytic virus immunotherapy has emerged as a promising therapy in cancer treatment, with numerous pharmaceutical companies focusing on research efforts and conducting clinical studies, combining oncolytic viruses with immune checkpoint inhibitors showing significant efficacy. The potential synergies between oncolytic virus immunotherapy and other treatments such as checkpoint inhibitors, chemotherapy, and radiotherapy are driving interest in combination therapies, enhancing efficacy and expanding the market opportunities.
  • According to the National Cancer Institute, a study by Moffitt Cancer Center demonstrated that integrating an oncolytic virus talimogene laherparepvec (TVEC) with systemic chemotherapy could enhance responses in high-risk early-stage triple-negative breast cancer.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Oncolytic virus immunotherapy market size was USD 302.6 million in 2023 and is expected to register 22.6% CAGR from 2024-2032 owing to the increasing incidence of cancer worldwide, which necessitated the development of novel and effective treatment options.

The herpes simplex virus (HSV) segment is expected to register 22.7% CAGR from 2024-2032 due to its ability to specifically infect and replicate within cancer cells while leaving healthy tissue unaffected.

North America oncolytic virus immunotherapy industry is expected to register 22.3% CAGR from 2024-2032 due to the growing patient population and rising cancer incidences in the region.

Amgen Inc., Creative Biolabs, Daiichi Sankyo Company Limited, Genelux Corporation, Oncorus Inc., Replimune Inc., Siga Technologies, Sorrento Therapeutics Inc., TILT Biotherapeutics, and Viralytics Ltd., are some of the major oncolytic virus immunotherapy companies worldwide.

Oncolytic Virus Immunotherapy Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 295
  • Countries covered: 19
  • Pages: 160
 Download Free Sample